Ocular toxoplasmosis: A global reassessment: Part II: Disease manifestations and management

American Journal of Ophthalmology

Volumn 137, Issue 1, 2004, Pages 1-17

  Holland, Gary N ^a,b  

^a JULES STEIN EYE INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIMALARIAL AGENT; ATOVAQUONE; AZITHROMYCIN; CORTICOSTEROID; PREDNISONE; PYRIMETHAMINE; SULFADIAZINE; SULFAMETHOXAZOLE; SULFONAMIDE; TRIMETHOPRIM;

CHORIORETINITIS; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; INFLAMMATION; NONHUMAN; PARASITE ISOLATION; PREVALENCE; PRIORITY JOURNAL; RETINITIS; SIDE EFFECT; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 0346729853     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2003.10.032     Document Type: Conference Paper

References (88)

1. Holland G.N. LX Edward Jackson Memorial Lecture. Ocular toxoplasmosis A global reassessment. Part I: Epidemiology and course of disease . Am J Ophthalmol. 136:2003;973-988.
2. Hogan M.J. Ocular toxoplasmosis XIV Edward Jackson Memorial Lecture . Am J Ophthalmol. 46:1958;467-494.
3. Wilder H.C. Toxoplasma chorioretinitis in adults. Arch Ophthalmol. 48:1952;127-136.
4. Holland G.N., O'Connor G.R., Belfort R. Jr, Remington J.S. Toxoplasmosis. Pepose J.S., Holland G.N., Wilhelmus K.R. Ocular infection & immunity. 1996;1183-1223 Mosby-Year Book, Inc. St. Louis, Missouri.
5. Hogan M.J., Kimura S.J., O'Connor G.R. Ocular toxoplasmosis. Arch Ophthalmol. 72:1964;592-600.
6. Friedmann C.T., Knox D.L. Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol. 81:1969;481-493.
7. O'Connor G.R. Manifestations and management of ocular toxoplasmosis. Bull NY Acad Med. 50:1974;192-210.
8. Smith J.R., Cunningham E.T. Atypical presentations of ocular toxoplasmosis. Curr Opin Ophthalmol. 13:2002;387-392.
9. Fardeau C., Romand S., Rao N.A., et al. Diagnosis of toxoplasmic retinochoroiditis with atypical clinical features. Am J Ophthalmol. 134:2002;196-203.
10. Moshfeghi DM, Lowder CY, Dodds EM, et al. Diagnostic approaches to severe, atypical toxoplasmosis mimicking acute retinal necrosis. Ophthalmology; forthcoming.
11. Holland G.N., Engstrom R., Glasgow B.J., et al. Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol. 106:1988;653-667.
12. Holland G.N. Ocular toxoplasmosis in the immunocompromised host. Int Ophthalmol. 13:1989;399-402.
13. Elkins B.S., Holland G.N., Opremcak E.M., et al. Ocular toxoplasmosis misdiagnosed as cytomegalovirus retinopathy in immunocompromised patients. Ophthalmology. 101:1994;499-507.
14. Cochereau-Massin I., LeHoang P., Lautier-Frau M., et al. Ocular toxoplasmosis in human immunodeficiency virus-infected patients. Am J Ophthalmol. 114:1992;130-135.
15. Gagliuso D.J., Teich S.A., Friedman A.H., Orellana J. Ocular toxoplasmosis in AIDS patients. Trans Am Ophthalmol Soc. 88:1990;63-86.
16. Matthews J.D., Weiter J.J. Outer retinal toxoplasmosis. Ophthalmology. 95:1988;941-946.
17. Doft B.H., Gass D.M. Punctate outer retinal toxoplasmosis. Arch Ophthalmol. 103:1985;1332-1336.
18. Silveira C., Belfort R. Jr., Muccioli C., et al. A follow-up study of Toxoplasma gondii infection in southern Brazil. Am J Ophthalmol. 131:2001;351-354.
19. Fish R.H., Hoskins J.C., Kline L.B. Toxoplasmosis neuroretinitis. Ophthalmology. 100:1993;1177-1182.
20. Roach E.S., Zimmerman C.F., Troost B.T., Weaver R.G. Optic neuritis due to acquired toxoplasmosis. Pediatr Neurol. 1:1985;114-116.
21. Holland G.N., Muccioli C., Silveira C., et al. Intraocular inflammatory reactions without focal necrotizing retinochoroiditis in patients with acquired systemic toxoplasmosis. Am J Ophthalmol. 128:1999;413-420.
22. Banta J.T., Davis J.L., Lam B.L. Presumed toxoplasmosic anterior optic neuropathy. Ocul Immunol Inflamm. 10:2002;201-211.
23. Berger B.B., Egwuagu C.E., Freeman W.R., Wiley C.A. Miliary toxoplasmic retinitis in acquired immunodeficiency syndrome. Arch Ophthalmol. 111:1993;373-376.
24. Bosch-Driessen L.E., Berendschot T.T., Ongkosuwito J.V., Rothova A. Ocular toxoplasmosis clinical features and prognosis of 154 patients . Ophthalmology. 109:2002;869-878.
25. Rothova A., Meenken C., Buitenhuis H.J., et al. Therapy for ocular toxoplasmosis. Am J Ophthalmol. 115:1993;517-523.
26. Hoerni B., Vallat M., Durand M., Pesme D. Ocular toxoplasmosis and Hodgkin's disease report of two cases . Arch Ophthalmol. 96:1978;62-63.
27. Yeo J.H., Jakobiec F.A., Iwamoto T., et al. Opportunistic toxoplasmic retinochoroiditis following chemotherapy for systemic lymphoma a light and electron microscopic study . Ophthalmology. 90:1983;885-898.
28. Nicholson D.H., Wolchok E.B. Ocular toxoplasmosis in an adult receiving long-term corticosteroid therapy. Arch Ophthalmol. 94:1976;248-254.
29. Johnson M.W., Greven G.M., Jaffe G.J., et al. Atypical, severe toxoplasmic retinochoroiditis in elderly patients. Ophthalmology. 104:1997;48-57.
30. Labalette P., Delhaes L., Margaron F., et al. Ocular toxoplasmosis after the fifth decade. Am J Ophthalmol. 133:2002;506-515.
31. Mets M.B., Holfels E., Boyer K.M., et al. Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol. 122:1996;309-324.
32. Yang P., Das P.K., Kijlstra A. Localization and characterization of immunocompetent cells in the human retina. Ocul Immunol Inflamm. 8:2000;149-157.
33. Schuman J.S., Weinberg R.S., Ferry A.P., Guerry R.K. Toxoplasmic scleritis. Ophthalmology. 95:1988;1399-1403.
34. Moorthy R.S., Smith R.E., Rao N.A. Progressive ocular toxoplasmosis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 115:1993;742-747.
35. Rehder J.R., Burnier M.B.J., Pavesio C.E., et al. Acute unilateral toxoplasmic iridocyclitis in an AIDS patient. Am J Ophthalmol. 106:1988;740-741.
36. Bosch-Driessen L.H., Karimi S., Stilma J.S., Rothova A. Retinal detachment in ocular toxoplasmosis. Ophthalmology. 107:2000;36-40.
37. Gentile R.C., Berinstein D.M., Oppenheim R., Walsh J.B. Retinal vascular occlusions complicating acute toxoplasmic retinochoroiditis. Can J Ophthalmol. 32:1997;354-358.
38. Schlaegel T.F.J., Weber J.C. The macula in ocular toxoplasmosis. Arch Ophthalmol. 102:1984;697-698.
39. Gilbert R.E., Dunn D.T., Lightman S., et al. Incidence of symptomatic Toxoplasma eye disease aetiology and public health implications . Epidemiol Infect. 123:1999;283-289.
40. Jones J.L., Kruszon-Moran D., Wilson M., et al. Toxoplasma gondii infection in the United States seroprevalence and risk factors . Am J Epidemiol. 154:2001;357-365.
41. Silveira C., Belfort R.J., Burnier M.J., Nussenblatt R. Acquired toxoplasmic infection as the cause of toxoplasmic retinochoroiditis in families. Am J Ophthalmol. 106:1988;362-364.
42. Glasner P.D., Silveira C., Kruszon-Moran D., et al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol. 114:1992;136-144.
43. Ronday M.J., Luyendijk L., Baarsma G.S., et al. Presumed acquired ocular toxoplasmosis. Arch Ophthalmol. 113:1995;1524-1529.
44. Montoya J.G., Remington J.S. Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. Clin Infect Dis. 23:1996;277-282.
45. Burnett A.J., Shortt S.G., Isaac-Rentom J., et al. Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology. 105:1998;1032-1037.
46. Pawelec G., Solana R., Remarque E., Mariani E. Impact of aging on innate immunity. J Leukoc Biol. 64:1998;703-712.
47. Grubeck-Loebenstein B., Wick G. The aging of the immune system. Adv Immunol. 80:2002;243-284.
48. Suzuki Y., Joh K., Orellana M.A., et al. A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice. Immunology. 74:1991;732-739.
49. Suzuki Y., Wong S.Y., Grumet F.C., et al. Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients. J Infect Dis. 173:1996;265-268.
50. Mack D.G., Johnson J.J., Roberts F., et al. HLA-class II genes modify outcome of Toxoplasma gondii infection. Int J Parasitol. 29:1999;1351-1358.
51. Nussenblatt R.B., Mittal K.K., Fuhrman S., et al. Lymphocyte proliferative responses of patients with ocular toxoplasmosis to parasite and retinal antigens. Am J Ophthalmol. 107:1989;632-641.
52. Meenken C., Rothova A., de Waal L.P., et al. HLA typing in congenital toxoplasmosis. Br J Ophthalmol. 79:1995;494-497.
53. Holland G.N., Cornell P.J., Park M.S., et al. An association between acute retinal necrosis syndrome and HLA-DQw7 and phenotype Bw62, DR4. Am J Ophthalmol. 108:1989;370-374.
54. Yamamoto J.H., Vallochi A.L., Silveira C., et al. Discrimination between patients with acquired toxoplasmosis and congenital toxoplasmosis on the basis of the immune response to parasite antigens. J Infect Dis. 181:2000;2018-2022.
55. O'Connor G.R. Factors related to the initiation and recurrence of uveitis XL Edward Jackson Memorial Lecture . Am J Ophthalmol. 96:1983;577-599.
56. Howe D.K., Sibley L.D. Toxoplasma gondii comprises three clonal lineages Correlation of parasite genotype with human disease . J Infect Dis. 172:1995;1561-1566.
57. Grigg M.E., Bonnefoy S., Hehl A.B., et al. Success and virulence in Toxoplasma as the result of sexual recombination between two distinct ancestries. Science. 294:2001;161-165.
58. Su C., Evans D., Cole R.H., et al. Recent expansion of Toxoplasma through enhanced oral transmission. Science. 299:2003;414-416.
59. Sibley L.D., Boothroyd J.C. Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature. 359:1992;82-85.
60. Su C., Howe D.K., Dubey J.P., et al. Identification of quantitative trait loci controlling acute virulence in Toxoplasma gondii. Proc Natl Acad Sci USA. 99:2002;10753-10758.
61. Barragan A., Sibley L.D. Transepithelial migration of Toxoplasma gondii is linked to parasite motility and virulence. J Exp Med. 195:2002;1625-1633.
62. Boothroyd J.C., Grigg M.E. Population biology of Toxoplasma gondii and its relevance to human infection do different strains cause different disease? Curr Opin Microbiol. 5:2002;438-442.
63. Reynolds M.G., Oh J., Roos D.S. In vitro generation of novel pyrimethamine resistance mutations in the Toxoplasma gondii dihydrofolate reductase. Antimicrob Agents Chemother. 45:2001;1271-1277.
64. Howe D.K., Honoré S., Derouin F., Sibley L.D. Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis. J Clin Microbiol. 35:1997;1411-1414.
65. Honoré S., Couvelard A., Garin Y.J., et al. [Genotyping of Toxoplasma gondii strains from immunocompromised patients]. Pathol Biol (Paris). 48:2000;541-557.
66. Fuentes I., Rubio J.M., Ramirez C., Alvar J. Genotypic characterization of Toxoplasma gondii strains associated with human toxoplasmosis in Spain direct analysis from clinical samples . J Clin Microbiol. 39:2001;1566-1570.
67. Dubey J.P., Graham D.H., Blackston C.R., et al. Biological and genetic characterisation of Toxoplasma gondii isolates from chickens (Gallus domesticus) from Sao Paulo, Brazil unexpected findings . Int J Parasitol. 32:2002;99-105.
68. Silveira CAM. A Maior Epidemia do Mundo. Toxoplasmose: Dúvidas e Controvérsias. Erechim, RS, Brazil: EdiFAPES, 2002:80.
69. Lehmann T., Blackston C.R., Parmley S.F., et al. Strain typing of Toxoplasma gondii: comparison of antigen-coding and housekeeping genes. J Parasitol. 86:2000;960-971.
70. Grigg M.E., Ganatra J., Boothroyd J.C., Margolis T.P. Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J Infect Dis. 184:2001;633-639.
71. Kong J.T., Grigg M.E., Uyetake L., et al. Serotyping of Toxoplasma gondii infections in humans using synthetic peptides. J Infect Dis. 187:2003;1484-1495.
72. Dubey J.P., Sharma S.P., Juranek D.D., et al. Characterization of Toxoplasma gondii isolates from an outbreak of toxoplasmosis in Atlanta, Georgia. Am J Vet Res. 42:1981;1007-1010.
73. Gilbert R.E., Stanford M.R., Jackson H., et al. Incidence of acute symptomatic Toxoplasma retinochoroiditis in south London according to country of birth. BMJ. 310:1995;1037-1040.
74. Holland G.N., Lewis K.G. An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol. 134:2002;102-114. Erratum in Am J Ophthalmol 2002;134:944.
75. Engstrom R.E., Holland G.N., Nussenblatt R.B., Jabs D.A. Current practices in the management of ocular toxoplasmosis. Am J Ophthalmol. 111:1991;601-610.
76. Isaac-Renton J., Bowie W.R., King A., et al. Detection of Toxoplasma gondii oocysts in drinking water. Appl Environ Microbiol. 64:1998;2278-2280.
77. Stanford M.R., See S.E., Jones L.V., Gilbert R.E. Antibiotics for toxoplasmic retinochoroiditis an evidence-based systematic review . Ophthalmology. 110:2003;926-931.
78. Gilbert RE, See SE, Jones LV, Stanford MS. Antibiotics versus control for toxoplasma retinochoroiditis (Cochrane review). The Cochrane Library, issue 1. Oxford: Update Software 2002.
79. Huskinson-Mark J., Araujo F.G., Remington J.S. Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii. J Infect Dis. 164:1991;170-171.
80. Pearson P.A., Piracha A.R., Sen H.A., Jaffe G.J. Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients. Ophthalmology. 106:1999;148-153.
81. Lopez J.S., De Smet M.D., Masur H., et al. Orally administered 566C80 for treatment of ocular toxoplasmosis in a patient with the acquired immunodeficiency syndrome. Am J Ophthalmol. 113:1992;331-333.
82. Bosch-Driessen L.H., Verbraak F.D., Suttorp-Schulten M.S., et al. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis. Am J Ophthalmol. 134:2002;34-40.
83. Sabates R., Pruett R.C., Brockhurst R.J. Fulminant ocular toxoplasmosis. Am J Ophthalmol. 92:1981;497-503.
84. O'Connor G.R., Frenkel J.K. Editorial Dangers of steroid treatment in toxoplasmosis. Periocular injections and systemic therapy . Arch Ophthalmol. 94:1976;213.
85. Silveira C., Belfort R. Jr., Muccioli C., et al. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol. 134:2002;41-46.
86. Rieger H. Zur Klinik der im Erwachsenenalter erworbenen Toxoplasmose. Klin Monatsbl Augenh. 119:1951;459-476.
87. Wising P. Akut adult toxoplasmos med lymfadenopathi och chorioretinit [Acute adult toxoplasmosis with lymphadenopathy and chorioretinitis]. Nord Med. 47:1952;563-565.
88. Jackson E. Our new journal [Editorial]. Am J Ophthalmol. 1:1918;68-70.